US FDA Designates Fast Track for Hanmi Pharm’s “LAPS Triple Agonist”

According to Hanmi Pharm, the US Food and Drug Administration (FDA) has designated LAPS Triple Agonist (HM15211), an innovative drug for the treatment of NASH (non-alcoholic steatohepatitis) manufactured by Hanmi, as a Fast Track drug. FDA generally designates the drug as “fast track” drugs when considering it must be developed quickly after the careful examination of new drugs with good…

Read more Arrow Right

Chongyoon Lim’s Representative Departed to China and Italy to Unveil the “Second Act” of Hanmi Pharm’s Development

Chongyoon Lim, the representative of Hanmi Science who started the cause of “total health care”, developed new drugs in China, explored targeted medical and health cooperation, and expanded relevant businesses in Italy. On November 25, representative Chongyoon Lim of Hanmi Science listened to In-seon Lee, director of Daegu-Gyeongbuk Free Economic Zone, explaining the support plan at the business contract ceremony…

Read more Arrow Right

Hanmi Science and Pohang University of Science and Technology (North Gyeongsang, South Korea) Join Hands to Develop New Drugs

Hanmi Science will make joint efforts with North Gyeongsang, Pohang City and Pohang University of Science and Technology (POSTECH) to develop new drugs. Hanmi Science executed an accelerator-based new drug development agreement with Pohang City and Pohang University of Science and Technology at POSTECH’s headquarters on the 25th. (From left) Dal-hee Lee, Head of the Government Office of North Gyeongsang…

Read more Arrow Right

COREE Group, an Affiliate of Hanmi Science, “Promotes FDA Approval of One-to-One Customized Health Platform”

COREE Group, an affiliate of Hanmi Science, will push its own platform, “life intervention”, into the US market with the ability to improve living habits and predict diseases. Its goal is to obtain a license for the medical software (SaMD•Software as Medical Device) from the Food and Drug Administration (FDA). It is undeniable that it will take several years to…

Read more Arrow Right

Chongyoon-Lim, the CEO of Hanmi Science Creating “Dong-Ui-Bo-Gam” of Bio-Bank.

“The future of Hanmi Pharmaceutical Group will lie in integrating life-care services through the customized health management system. This will be achieved by accumulating big data and sharing medical experiences based on Bio-Bank, just like Korean medical book Dong-Ui-Bo-Gam (registered in Memory of the World), which had integrated the East Asian medicine” Chongyoon-Lim, the CEO of Hanmi Science (Hanmi Pharmaceutical…

Read more Arrow Right

In Rome, the first International Symposium on the care of mother and child

Organized by the Centre Ofmom (Ex Mater Ecclesiae), the event brought together national and international experts on postpartum and intestinal microbiota issues. On October 26 took place in Rome, Via della Pineta Sacchetti 502, the first International Symposium on the care of the mother and child, established by the Centre Ofmom (formerly Mater Ecclesiae). The Ofmom centres, already operating in…

Read more Arrow Right

The first Ofmom Centre for postpartum care of mothers and babies is opening in Rome, Italy

Coree Group, from precious eastern philosophy to recognised disciplines and therapies that guarantee mother’s wellbeing, total safety and health recovery After childbirth, mothers face a challenging stage for their psychophysics recovery. Professionals suggest that, besides breastfeeding and their return home (from medical centre), mothers take on particularly fragile and sensitive circumstances that would require the constant presence of their partner…

Read more Arrow Right

Hanmi Science Establishes a BioBank for Mother and Child in Rome, Italy

The “worldwide first biobank for Mother and Child”, cooperating with Università Cattolica del Sacro Cuore and Policlinico Universitario Agostino Gemelli. Hanmi Science establish a biobank for mother and child  in Italy. “COREE Group”, headquartered in Milan, said on the 27th of this month: Hanmi Science has signed and concluded an agreement with Università Cattolica del Sacro Cuore and Affiliated Hospital…

Read more Arrow Right

Hanmi Pharmaceutical Sungki-Lim & Chongyoon-Lim Signed and Concluded the Public Medical Research and Development Agreement with Fondazione Policlinico Universitario Agostino Gemelli of Rome, Italy

Establish “Woman Centre” for prenatal and postnatal management in Rome and set up a new practice course for nursing. On October 5, 2017, Hanmi Pharmaceutical signed and concluded a cooperative research and development agreement for public medical service of South Korea and Italy with Fondazione Policlinico Universitario Agostino Gemelli (IRCCS) and Università Cattolica del Sacro Cuore. The key point of…

Read more Arrow Right

Contact us
Ofmom Italy |Coree Srl
Piazza S. Babila 5, 20122 Milan, Italy


+39 02 36636 376

For further information on the proper intake of the products, it is advisable to always contact your doctor or pharmacist.
The information on this site cannot in any way replace the direct relationship between health professional and patient. It is therefore necessary to always consult your doctor and / or pharmacist.